BCDA - BioCardia, Inc.
1.18
-0.025 -2.119%
Share volume: 102,411
Last Updated: 03-06-2026
Pharmaceutical Products/Biological Products, Except Diagnostic Substances:
0.19%
PREVIOUS CLOSE
CHG
CHG%
$1.20
-0.03
-0.02%
View ratios
| Fiscal Date | 03-31-2024 | 06-30-2024 | 09-30-2024 | 12-31-2024 | 03-31-2025 | 06-30-2025 | 09-30-2025 | |
|---|---|---|---|---|---|---|---|---|
| Fiscal Quarter | Q1 2024 | Q2 2024 | Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | |
| Report Date | 05-14-2024 | 08-13-2024 | 11-13-2024 | 03-26-2025 | 05-14-2025 | 08-11-2025 | 11-12-2025 | |
| Total revenue | 55.000 K | 3.000 K | 0.000 | -58.000 K | 0.000 | 0.000 | 0.000 | |
| Cost of revenue | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Gross profit | 55.000 K | 3.000 K | 0.000 | -58.000 K | 0.000 | 0.000 | 0.000 | |
| -94.55% | -100.00% | inf% | 100.00% | nan% | nan% | |||
| Operating expenses | 2.330 M | 1.652 M | 1.756 M | 2.321 M | 2.726 M | 2.051 M | 1.488 M | |
| Selling general and admin | 1.089 M | 852.000 K | 825.000 K | 906.000 K | 1.196 M | 683.000 K | 552.000 K | |
| Research and development | 1.241 M | 800.000 K | 931.000 K | 1.415 M | 1.530 M | 1.368 M | 936.000 K | |
| Total expenses | 2.330 M | 1.652 M | 1.756 M | 2.321 M | 2.726 M | 2.051 M | 1.488 M | |
| -29.10% | 6.30% | 32.18% | 17.45% | -24.76% | -27.45% | |||
| Operating income | -2.275 M | -1.649 M | -1.756 M | -2.321 M | -2.726 M | -2.051 M | -1.488 M | |
| Ebit | -2.267 M | -1.649 M | -1.737 M | -2.321 M | -2.726 M | -2.051 M | -1.488 M | |
| Pretax income | -2.267 M | -1.649 M | -1.737 M | -2.293 M | -2.712 M | -2.049 M | -1.483 M | |
| -27.26% | 5.34% | 32.01% | 18.27% | -24.45% | -27.62% | |||
| Income tax | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Net income basic | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Net income | -2.267 M | -1.646 M | -1.737 M | -2.296 M | -2.712 M | -2.049 M | -1.483 M | |
| 27.39% | -5.53% | -32.18% | -18.12% | 24.45% | 27.62% |